Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Research
China approved the first solid tumor CAR-T. Will the US follow?
While satri-cel may soon broaden its reach to more Chinese patients, the game-changing therapy is unlikely to hit the American market anytime soon.
Darren Incorvaia
Jun 30, 2026 10:00am
Caribou boosts case for off-the-shelf CAR-T v. autologous
Jun 11, 2026 8:00am
Cabaletta's autoimmune CAR-T strategy is built on 'durability'
Jun 4, 2026 8:26am
ASCO: Legend scientific founder returns with new CAR-T ambition
May 29, 2026 2:00pm
Has Novartis’ T-Charge push been overtaken by in vivo CAR-Ts?
May 22, 2026 8:28am
Liminatus pays $320M in stock for CAR-T biotech InnocsAI
May 21, 2026 8:09am
